Furthermore, TAZ-AXL-CTGF co-overexpression, which defines both the expression of TAZ and its transcriptional activity on target gene expression, is a novel prognostic indicator, that is independent of tumor grade and stage, for colon cancer patients. The gene discussed is AXL; the disease is neoplasm.